C
catherinecherub
Guest
NICE guidance on sensor augmented pumps
Tuesday 29 March 2016
New NICE guidance recommends that people with Type 1 diabetes who have disabling hypoglycaemia (hypos) despite being on an insulin pump should be given access to a sensor-augmented pump to help them better manage their blood glucose levels. Existing NICE guidance around who is given a regular insulin pump has not changed. This new guidance is focused on who should get a sensor augmented pump.
Diabetes UK supports the use of an integrated sensor-augmented pump therapy system, which combines continuous glucose monitoring (CGM) with continuous subcutaneous insulin infusion (CSII), for patients who have disabling hypos. However the charity is concerned that the new NICE guidance does not encompass all available technology that could potentially help patients who have disabling hypos to manage their condition.
www.diabetes.org.uk/About_us/News/NICE-guidance-on-sensor-augmented-pumps/
Tuesday 29 March 2016
New NICE guidance recommends that people with Type 1 diabetes who have disabling hypoglycaemia (hypos) despite being on an insulin pump should be given access to a sensor-augmented pump to help them better manage their blood glucose levels. Existing NICE guidance around who is given a regular insulin pump has not changed. This new guidance is focused on who should get a sensor augmented pump.
Diabetes UK supports the use of an integrated sensor-augmented pump therapy system, which combines continuous glucose monitoring (CGM) with continuous subcutaneous insulin infusion (CSII), for patients who have disabling hypos. However the charity is concerned that the new NICE guidance does not encompass all available technology that could potentially help patients who have disabling hypos to manage their condition.
www.diabetes.org.uk/About_us/News/NICE-guidance-on-sensor-augmented-pumps/
